Hansen Gwenn: insider trades.
Hansen Gwenn reported 10 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($336K), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Hansen Gwenn
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | Officer · Chief Scientific Officer | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Nurix Therapeutics, Inc. | S | 1,452 | $25.47 | 117,227 | Form 4 |
| 2026-09-01 | Nurix Therapeutics, Inc. | M | 1,452 | $1.86 | 118,679 | Form 4 |
| 2026-08-05 | Nurix Therapeutics, Inc. | S | 4,356 | $25 | 117,227 | Form 4 |
| 2026-08-05 | Nurix Therapeutics, Inc. | M | 4,356 | $1.86 | 121,583 | Form 4 |
| 2026-08-04 | Nurix Therapeutics, Inc. | S | 2,611 | $24.64 | 117,227 | Form 4 |
| 2026-08-04 | Nurix Therapeutics, Inc. | S | 1,500 | $23.87 | 119,838 | Form 4 |
| 2026-07-30 | Nurix Therapeutics, Inc. | M | 3,572 | $0 | 125,185 | Form 4 |
| 2026-07-30 | Nurix Therapeutics, Inc. | S | 3,847 | $23.38 | 121,338 | Form 4 |
| 2026-07-30 | Nurix Therapeutics, Inc. | M | 2,858 | $0 | 121,613 | Form 4 |
| 2026-07-30 | Nurix Therapeutics, Inc. | M | 3,750 | $0 | 118,755 | Form 4 |
Questions
What stock did Hansen Gwenn buy or sell?
Hansen Gwenn reported 10 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($336K), across 1 company.
Is Hansen Gwenn the same person as other filers with this name?
This page covers SEC CIK 1817160 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/hansen-gwenn-1817160.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.